YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

AstraZeneca to buy Alexion for $39B

Posted online

Britain’s AstraZeneca is slated to purchase U.S. drugmaker Alexion Pharmaceuticals.

The deal is valued at $39 billion in cash and stock.

AstraZeneca would bolster its positions in immunology and rare diseases through the deal.

Read more from Reuters.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.

Nixa Superintendent Gearl Loden weighs in on A-F grade cards.

Most Read
Update cookies preferences